Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic. Differentiation and lymph node metastasis in endometrial carcinoma

Cancer

Volumn 85, Issue 2, 1999, Pages 453-464

  Saegusa, Makoto ^a   Miki, Hashimura ^a   Hara, Atsuko ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometrial carcinoma; Endometrial hyperplasia; Estrogen receptor; Gene deleted in colon carcinoma (DCC); Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ARTICLE; CANCER GRADING; DISEASE ASSOCIATION; DISEASE COURSE; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METASTASIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; BLOTTING, SOUTHERN; CELL DIFFERENTIATION; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE DELETION; GENES, DCC; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0345369679     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990115)85:2<453::AID-CNCR25>3.0.CO;2-5     Document Type: Article

References (27)

1. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49-56.
2. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon AC, Presinger P, et al. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 1994;19:525-31.
3. Hedrick L, Cho KR, Fearon ER, Wu T-C, Kinzler KW, Vogelstein B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 1994;8:1174-83.
4. Gao X, Honn KV, Grignon D, Sakr W, Chen YQ. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 1993;53:2723-7.
5. Cropp CS, Lidereau R, Campbell G, Champene MH, Callahan R. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Proc Natl Acad Sci USA 1990;87:7737-41.
6. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 1992;52:6525-30.
7. Reyes-Mugica M, Rieger-Christ K, Ohgaki H, Ekstrand BC, Helei M, Kleinman G, et al. Loss of DCC expression and glioma progression. Cancer Res 1997;57:382-6.
8. Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 1995;10:1581-6.
9. Enomoto T, Fujita M, Cheng C, Nakashima R, Ozaki M, Inoue M, et al. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br J Cancer 1995;71:462-7.
10. Gima T, Kato H, Honda T, Imamura T, Sasazuki T, Wake N. DCC gene alteration in human endometrial carcinomas. Int J Cancer 1994;57:480-5.
11. Creasman WT. Announcement, FIGO stages: 1988 revision. Gynecol Oncol 1989;35:125-7.
12. Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy N, Voet R, et al. The significance of squamous differentiation in endometrial carcinoma: data from a Gynecologic Oncology Group study. Cancer 1991;68:2293-302.
13. Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele G Jr., et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996;335:1727-32.
14. Saegusa M, Kamata Y, Isono M, Okayasu I. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas. J Pathol 1996;180:275-82.
15. Reale MA, Hu G, Zafar AI, Getzenberg RH, Levine SM, Fearon ER. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res 1994;54:4493-501.
16. Horstmann MA, Posl M, Scholz RB, Anderegg B, Simon P, Baumgaertl K, et al. Frequent reduction or loss of DCC gene expression in human osteosarcoma. Br J Cancer 1997;75: 1309-17.
17. Saegusa M, Takano Y, Kamata Y, Okayasu I. Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas. J Cancer Res Clin Oncol 1996;122:427-32.
18. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia: a long-term study of "untreated" hyperplasia in 170 patients. Cancer 1985;56:403-12.
19. Goi T, Yamaguchi A, Nakagawara G, Urano T, Shiku H, Furukawa K. Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. Br J Cancer 1998;77:466-71.
20. Hohne MW, Halatsch M-E, Kahl GF, Weinel RJ. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 1992; 52:2616-9.
21. Itoh F, Hinoda Y, Ohe M, Ban T, Endo T, Imai K, et al. Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer 1993;53:260-3.
22. Kikuchi-Yanoshita R, Konishi M, Fukunari H, Tanaka K, Miyaki M. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 1992;52:3801-3.
23. Ekstrand BC, Mansfield TA, Bigner SH, Fearon ER. DCC expression is altered by multiple mechanisms in brain tumours. Oncogene 1995;11:2393-402.
24. Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M, et al. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus. Cancer Res 1991;51:5632-6.
25. Imamura T, Arima T, Kato H, Miyamoto S, Sasazuki T, Wake N. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int J Cancer 1992;51:47-52.
26. Kong X-T, Choi SH, Inoue A, Xu F, Chen T, Takita J, et al. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Cancer Res 1997; 57:3772-8.
27. Saegusa M, Okayasu I. Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas. J Pathol 1997; 182:429-36.